For the quarter ending 2025-09-30, BLZE had -$3,110K decrease in cash & cash equivalents over the period. $2,601K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -3,778 | -16,421 |
| Noncash lease expense on operating leases | 1,401 | 1,964 |
| Depreciation and amortization | 6,044 | 13,238 |
| Impairment loss on right-of-use assets | 0 | 59 |
| Stock-based compensation | 5,445 | 14,663 |
| Gain on disposal of assets | 115 | 248 |
| Other | 18 | 407 |
| Accounts receivable | 122 | 1,409 |
| Prepaid expenses | 712 | -354 |
| Other current assets | -28 | 1,722 |
| Other assets | 877 | 827 |
| Accounts payable, accrued expenses and other current liabilities | -434 | 441 |
| Deferred revenue and other liabilities, non-current | 210 | 88 |
| Operating lease liabilities | -1,365 | -2,099 |
| Net cash provided by operating activities | 5,743 | 8,488 |
| Purchases of marketable securities | 6,264 | 28,132 |
| Maturities of marketable securities | 3,457 | 18,884 |
| Proceeds from disposal of property and equipment | 124 | 30 |
| Purchases of property and equipment | 3,142 | 1,287 |
| Capitalized internal-use software costs | 1,706 | 4,184 |
| Net cash used in investing activities | -7,531 | -14,689 |
| Principal payments on finance leases and lease financing obligations | 4,621 | 9,277 |
| Payment of offering costs | 0 | 20 |
| Proceeds from debt facility | 2,454 | 0 |
| Payment of debt issuance costs | 48 | 554 |
| Purchase of treasury stock | 1,185 | - |
| Principal payments on insurance premium financing | 0 | 0 |
| Proceeds from exercises of stock options | 2,852 | 1,894 |
| Taxes paid for net share settlement of equity awards | 774 | 819 |
| Proceeds from espp | 0 | 1,388 |
| Net cash used in financing activities | -1,322 | -7,388 |
| Net decrease in cash and cash equivalents and restricted cash | -3,110 | -13,589 |
| Cash and cash equivalents at beginning of period | 45,776 | - |
| Cash and cash equivalents at end of period | 29,077 | - |
Backblaze, Inc. (BLZE)
Backblaze, Inc. (BLZE)